top of page

High Accuracy

Shown in Clinical Performance Trial

SpotitEarly’s high accuracy in detecting early-stage cancer was demonstrated in the Rainbow Study, a large-scale clinical trial conducted in partnership with three leading healthcare institutions in Israel. Results were impressive both in terms of sensitivity and specificity. Two more trials are starting as we breathe…

Increasing Adoption of Cancer Screening

Early Detection
Is One Breath Away

A new approach for cancer pre-screening, with a single at-home test for multiple cancer types, all based on one breath sample.

Accurate

94% SENSITIVITY & SPECIFICITY IN EARLY STAGE CANCER

Easy

A SIMPLE BREATH
SAMPLE COLLECTED AT HOME IN MINUTES

Accessible

AFFORDABLE, AVAILABLE TO EVERYONE, ANYWHERE

from-to.png

FROM

Multiple tests for different cancers

TO

One test for multiple cancers

fig 3.png

Prostate cancer

fig 1.png

Breast cancer

fig 4.png

Lung cancer

fig 2.png

Colorectal cancer

SpotitEarly’s technology aims to enable more frequent testing of much wider audiences at a fraction of the cost. We’re committed to saving lives and improving clinical outcomes for everyone, everywhere.

LET'S SPOTITEARLY TO SAVE MORE LIVES.

cube_bg.png

Human breath contains over 1,000 Volatile Organic Compounds or VOCs. Science has shown that VOCs represent rich sources of biomarkers associated with metabolic processes and diseases in the body, each identified
by a significant odor signature, including cancer. SpotitEarly harnesses the science of scent to detect cancerous VOCs in exhaled breath samples.

THE SCIENCE

Breath Carries
the Odor Signature of Cancer

Nature's Intel Meets AI

Biosensors, Data Science, Biochemistry and Nanotechnology Join Forces

The most sophisticated odor sensors we can find as of today were actually designed by nature. But we’ve developed the key to transforming their signals into precise clinical-level information.

LUCID, our cutting-edge AI tech platform increases accuracy of results, offering a cancer pre-screening solution that is reliable, scalable, and with the proper resources,
replicable around the globe.

The LUCID platform integrates Proprietary Hardware Devices and Software

While canines sniff breath samples with their highly sensitive olfactory system to detect cancer odor signatures, LUCID collects and analyzes thousands of data points every second, providing verification regarding the canine's detection signal.

Optimized
Interpretation

Validated
Conclusions

Constant
Learning

Optimized Interpretation

Adaptive Calibration

Constant Learning

As a cancer screening expert, I've rigorously reviewed the SpotitEarly solution's clinical validation. I am deeply impressed by its potential to  revolutionize cancer screening. Its innovative approach and proven effectiveness set a new standard in early detection. I fully endorse SpotitEarly as a game-changer in our field.

Prof. Nadir Arber

HEAD OF THE INTEGRATED CANCER PREVENTION CENTER, TEL AVIV SOURASKY MEDICAL CENTER

Clinical Partners

University

of Pennsylvania

Tel Aviv Sourasky

Medical Center

Hadassah

Medical Center

Rambam Health

Care Campus

Assuta

Hospital

As an expert in scent nanotechnology, I have closely followed the clinical validation of the SpotitEarly solution. The seamless integration of natural scent detection principles with advanced AI is a true breakthrough in the field. Utilizing Volatile Organic Compounds (VOCs) for cancer detection, is an innovative approach that marks a major leap forward. I am excited about its potential to transform cancer detection.

Dr. Reef Einoch Amor

PHD, DIRECTOR OF CHEMICAL ANALYSIS, SpotitEarly

customer-masked.png

Accessible to All, Anytime

Today, only 14% of cancers in the U.S. are diagnosed following a recommended screening test. With an easy-to-use breath collection kit now more people could potentially take the test at home and get pre-screened for multiple types of cancer even at early stages.

Key Benefits:

DSC01478-Edit-3.jpg
  • At-home collection

  • Non-invasive

  • Affordable and accessible

  • No side effects, no preparation needed

  • No clinic visits required

  • Online prescription, no appointments or lost work days

94% Accuracy

Very high sensitivity
and specificity in early stage cancer

Easy

A simple breath
sample collected at home in minutes

Accessible

Affordable, available to everyone,

anywhere

Optimized
Interpretation

Validated
Conclusions

Constant
Learning

Optimized
Interpretation

Validated
Conclusions

Constant
Learning

from-to.png

FROM

Multiple tests for different cancers

TO

One test for multiple cancers

Focus on:

fig 1.png

Breast

fig 4.png

Lung

fig 2.png

Colorectal

fig 3.png

Prostate

bottom of page